SCHEMBL19081924

SCHEMBL19081924

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6oc7cc8c(cc7c6c5)sc5c6ccccc6ccc85)cc4)c4ccccc34)cccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.34
CYP1B1 Q16678 5/20 0.34
CYP1A2 P05177 3/20 0.34
PRKDC P78527 1/20 0.32
PSD A5PKW4 1/20 0.32
PIM1 P11309 1/20 0.32
KMT2A Q03164 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
ALOX5 P09917 1/20 0.31
MAPK1 P28482 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081788 0.96 CYP1A1 (0.35) CYP1A1CYP1B1CYP1A2PRKDCPSD
SCHEMBL19082051 0.95 CYP1A1 (0.33) CYP1A1CYP1B1CYP1A2PRKDCPSD
SCHEMBL19108990 0.90 PRKDC (0.37) CYP1A1CYP1B1CYP1A2PRKDCPSD
SCHEMBL19076683 0.90 CYP1A1 (0.33) CYP1A1CYP1B1CYP1A2PRKDCPSD
SCHEMBL19082037 0.88 PRKDC (0.35) CYP1A1CYP1B1CYP1A2PRKDCPSD
SCHEMBL24341926 0.88 PRKDC (0.37) CYP1A1CYP1B1CYP1A2PRKDCPSD
SCHEMBL24342555 0.87 PRKDC (0.33) CYP1A1CYP1B1CYP1A2PRKDCPSD
SCHEMBL19082266 0.87 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2ALDH1A1MAPT
SCHEMBL19081833 0.86 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2KMT2AKDM4E
SCHEMBL19076819 0.86 CYP1A1 (0.33) CYP1A1CYP1B1CYP1A2PRKDCPSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.